IMCYSE SA

Patent Applications and Registrations

Patent applications and USPTO patent grants for IMCYSE SA.The latest application filed is for "immunogenic peptides with new oxidoreductase motifs".

Company Profile

9.10.19

IMCYSE SA - Liege BE
IMCYSE SA - Sart-Tilman BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Immunogenic Peptides With New Oxidoreductase Motifs App 20220288179 - ERAK; Milos	2022-09-15
Peptides and methods for the treatment of diabetes Grant 11,407,795 - Vander Elst , et al. August 9, 2	2022-08-09
Immunogenic Peptides For Use In The Prevention And/or Treatment Of Infectious Diseases, Autoimmune Diseases, Immune Responses To Allofactors, Allergic Diseases, Tumors, Graft Rejection And Immune Responses Against Viral Vectors Used For Gene Therapy Or Gene Vaccination App 20220119778 - SAINT-REMY; Jean-Marie	2022-04-21
Method for the detection, preparation and depletion of CD4+ t lymphocytes Grant 11,226,332 - Saint-Remy , et al. January 18, 2	2022-01-18
Immunogenic Peptides With Improved Oxidoreductase Motifs App 20210401976 - ERAK; Milos ; et al.	2021-12-30
Peptides And Methods For The Treatment Of Diabetes App 20200407406 - VANDER ELST; Luc ; et al.	2020-12-31
Novel Immunogenic Peptides App 20200397911 - SAINT-REMY; Jean-Marie ; et al.	2020-12-24
Peptides and methods for the treatment of diabetes Grant 10,808,016 - Vander Elst , et al. October 20, 2	2020-10-20
Animal models for evaluating pharmaceutical compounds Grant 10,729,791 - Saint-Remy , et al.	2020-08-04
Method For The Detection, Preparation And Depletion Of Cd4+ T Lymphocytes App 20200103407 - SAINT-REMY; Jean-Marie ; et al.	2020-04-02
Peptides And Methods For The Treatment Of Diabetes App 20190352348 - Vander Elst; Luc ; et al.	2019-11-21
Novel Immunogenic Cd1d Binding Peptides App 20190106477 - Vander Elst; Luc	2019-04-11
Improved Methods And Compounds For Eliminating Immune Responses To Therapeutic Agents App 20180258154 - Saint-Remy; Jean-Marie ; et al.	2018-09-13
Novel Immunogenic Peptides App 20180228912 - Saint-Remy; Jean-Marie ; et al.	2018-08-16
Novel Animal Models For Evaluating Pharmaceutical Compounds App 20160339121 - SAINT-REMY; Jean-Marie ; et al.	2016-11-24
Methods For Induction Of Antigen-specific Regulatory T Cells App 20160250255 - SAINT-REMY; Jean-Marie ; et al.	2016-09-01
CD4+ T-cells with cytolytic properties Grant 9,394,517 - Saint-Remy July 19, 2	2016-07-19
Immunogenic Peptides And Their Use In Transplantation App 20160108103 - Saint-Remy; Jean-Marie	2016-04-21
Method For The Detection, Preparation And Depletion Of Cd4+ T Lymphocytes App 20160091492 - SAINT-REMY; Jean-Marie ; et al.	2016-03-31
Immunogenic peptides and their use in transplantation Grant 9,248,171 - Saint-Remy February 2, 2	2016-02-02
Methods For Induction Of Antigen-specific Regulatory T Cells App 20150125880 - Saint-Remy; Jean-Marie	2015-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.